Work

Avibactam Tomilopil Form 1: A Rare Pharmaceutical Mesophase

Year: 2025

Type: article

Source: Crystal Growth & Design

DOI: 10.1021/acs.cgd.5c00904

Authors: Kevin DeBoyace, Maryam S. Sadeghi, Erika L. Buckle, Marissa Puzan, Geoffrey P. F. Wood, Kyla Suszynski, Brian Samas, Alpana A. Thorat, Jaypee Quino, Zhuocen Yang, GuangXu Sun, Michael A. Bellucci

Institutions: Pfizer (United States), XtalPi (China)

Language: English

Topic: Crystallization and Solubility Studies

Subfield: Materials Chemistry

Field: Materials Science

Domain: Physical Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4414577407

FWCI:

Cites: 29

Cited by:

Related to: